Skip to main content

Market Overview

AbbVie Receives An Upgrade From Vetr

Share:

On Tuesday, the Vetr crowd upgraded their rating for AbbVie Inc (NYSE: ABBV), from 3 stars (Hold), issued four days ago, to 4.5 stars (Strong Buy). At the time of the upgrade, crowd sentiment for AbbVie was generally positive, with 63 percent of Vetr user ratings bullish.

Share price in the biopharma company has been trending up since mid-February, gaining over 8.5 percent. In that span, AbbVie released a solid Q4 earnings report, meeting an EPS estimates and just missing revenue estimates. The stock also picked up an upgrade from Goldman Sachs who put the stock at Buy.

By today's close, AbbVie was down slightly on the day at $65.67

Learn how crowdsourced ratings could help you time the market.

Currently, the Vetr crowd's average target price for AbbVie is up at $74.72, which is above the average analyst target price of $70.33. Less than 2 percent of Vetr users are holding ABBV in their watch lists

Latest Ratings for ABBV

DateFirmActionFromTo
Feb 2021SVB LeerinkMaintainsOutperform
Jan 2021Morgan StanleyMaintainsOverweight
Dec 2020SVB LeerinkMaintainsOutperform

View More Analyst Ratings for ABBV
View the Latest Analyst Ratings

 

Related Articles (ABBV)

View Comments and Join the Discussion!

Posted-In: VetrBiotech Upgrades Price Target Crowdsourcing Analyst Ratings

Latest Ratings

StockFirmActionPT
KRYSHC Wainwright & Co.Maintains103.0
OTRKRBC CapitalDowngrades32.0
EVHCanaccord GenuityMaintains24.0
BMRNCanaccord GenuityMaintains91.0
ONTFCanaccord GenuityInitiates Coverage On65.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com